Differential Neuroprotection and Risk for Bleeding From Activated Protein C With Varying Degrees of Anticoagulant Activity
- 1 May 2009
- journal article
- research article
- Published by Ovid Technologies (Wolters Kluwer Health) in Stroke
- Vol. 40 (5), 1864-1869
- https://doi.org/10.1161/STROKEAHA.108.536680
Abstract
Background and Purpose— Activated protein C (APC), a protease with anticoagulant and cytoprotective activities, protects neurons and endothelium from ischemic injury. Drotrecogin-alfa activated, a hyperanticoagulant form of human recombinant APC, is currently being studied in patients with ischemic stroke. How changes in APC anticoagulant activity influence APC’s neuroprotection and risk for bleeding is not clear. Methods— We used neuronal and brain endothelial cell injury models and middle cerebral artery occlusion in mice to compare efficacy and safety of drotrecogin-alfa activated and human 3K3A-APC, an APC nonanticoagulant mutant. Results— Drotrecogin-alfa activated and 3K3A-APC exhibited 148% and 10% of plasma-derived APC’s anticoagulant activity and differ in the carbohydrate content. 3K3A-APC protected mouse neurons from N -methyl- d -aspartate-induced apoptosis and human brain endothelial cell from oxygen-glucose deprivation with 1.8- and 3.1-fold greater efficacy than drotrecogin-alfa activated. Given 5 minutes before transient middle cerebral artery occlusion, 3K3A-APC and drotrecogin-alfa activated (0.5 and 2 mg/kg intravenously) reduced comparably and dose-dependently the infarction lesion up to 85%. 3K3A-APC, but not drotrecogin-alfa activated, improved neurological score dose-dependently ( P Conclusions— Nonanticoagulant 3K3A-APC exhibits greater neuroprotective efficacy with no risk for bleeding compared with drotrecogin-alfa activated, a hyperanticoagulant form of APC.Keywords
This publication has 32 references indexed in Scilit:
- ALS-causing SOD1 mutants generate vascular changes prior to motor neuron degenerationNature Neuroscience, 2008
- Endotoxemia and sepsis mortality reduction by non-anticoagulant–activated protein CThe Journal of Experimental Medicine, 2007
- Effect of Targeted Deletion of the Heme Oxygenase-2 Gene on Hemoglobin Toxicity in the StriatumJournal of Cerebral Blood Flow & Metabolism, 2005
- Protease-activated Receptor-1 Signaling by Activated Protein C in Cytokine-perturbed Endothelial Cells Is Distinct from Thrombin SignalingJournal of Biological Chemistry, 2005
- Activated protein C blocks p53-mediated apoptosis in ischemic human brain endothelium and is neuroprotectiveNature Medicine, 2003
- Molecular Characterization of an Extended Binding Site for Coagulation Factor Va in the Positive Exosite of Activated Protein CPublished by Elsevier BV ,2002
- Toxic Effect of Hemoglobin on Spinal Cord Neurons in CultureJournal of Neurotrauma, 1998
- Chronic Nicotine Treatment Enhances Focal Ischemic Brain Injury and Depletes Free Pool of Brain Microvascular Tissue Plasminogen Activator in RatsJournal of Cerebral Blood Flow & Metabolism, 1997
- Neurotoxicity of hemoglobin in cortical cell cultureNeuroscience Letters, 1993
- Bilateral cutaneous stimulation of the somatosensory system in hemidecorticate rats.Behavioral Neuroscience, 1984